Moderna
AI Titan
Rationale: Company is an AI Titan with high valuation, profitability, and revenue.
| Funding Stage | IPO (2018) |
|---|---|
| Total Funding | $5.2B |
| Annual Revenue | $20.0B |
| AI Patents | Multiple AI-powered drug development patents |
| Growth Rate | 60% |
| Market Potential | High |